Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Pharmaceutical Technology
APRIL 25, 2024
The first episode in Sterling's podcast series on digital dealmaking in life sciences puts a spotlight on corporate culture
Pharmaceutical Technology
APRIL 25, 2024
The first episode in Sterling's podcast series on digital dealmaking in life sciences puts a spotlight on corporate culture
Pharma Mirror
APRIL 17, 2024
As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE Life Sciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- FASTRO, to its esteemed Board of Directors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 8, 2023
In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.
Pharmaceutical Technology
APRIL 22, 2024
Wave Life Sciences Ltd patent reveals a groundbreaking method for synthesizing high-purity oligonucleotides with increased yields. Learn more about this innovative process now!
Pharma Mirror
JANUARY 19, 2024
As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.
Bio Pharma Dive
FEBRUARY 27, 2023
Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.
Pharmaceutical Technology
APRIL 20, 2023
European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).
Let's personalize your content